Grants for City or township governments - Health

The grant titled "Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)" is aimed at funding the development and implementation of a Data Coordinating Center to manage data, provide statistical support, and ensure overall coordination for a multi-site clinical trial focused on preventing cardiovascular disease in young adults at high risk, while also promoting community engagement, diversity, and health equity.

On November 6, 2018, California voters passed Proposition 4, the Children's Hospital Bond Act of 2018. The purpose of the program is to improve the health and welfare of California’s critically ill children, by providing a stable and ready source of funds for capital improvement projects for eligible hospitals. The California Health Facilities Financing Authority (CHFFA) is responsible for administering the program. Language in Proposition 4 identifies 13 children’s hospitals in California (referred to as “Children’s Hospitals”) as eligible for $1.35 billion in funding. The 13 Children's Hospitals designated by statute are the same as the 13 hospitals that received grants under the first two Children’s Hospital Programs also administered by CHFFA and enacted by Proposition 61 in 2004 and Proposition 3 in 2008. The 13 Children’s Hospitals consist of eight private nonprofit Children’s Hospitals and five University of California Children’s Hospitals. Grant awards for each private nonprofit Children’s Hospital was limited to $135 million, less costs of issuance and administrative costs. Grant awards for each University of California Children’s Hospital was limited to $54 million, less costs of issuance and administrative costs. Costs of issuance are $0.75 per $1,000 of the authorized grant award and administrative costs are $10.00 per $1,000 of the authorized grant award. Applications are accepted on an ongoing basis until June 30, 2033 and are due the first business day of each month, except October and November, and will be presented to the Authority the following month. For the month of October, Applications are due on October 7. Applications received on October 7 will be presented for Authority consideration at a regularly scheduled meeting in December or January. Applications are not accepted in November. Applications shall be submitted in duplicate to the Authority. Each Children’s Hospital may apply more than once. Submit completed Application by mail or in-person to: California Health Facilities Financing Authority Children’s Hospital Program 901 P Street Room 313 Sacramento, CA 95814

The "Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults" grant aims to fund a network of clinical trials that will study the safety and potential effectiveness of psychedelic drugs in treating chronic pain in older adults, with a focus on those aged 75 and above.

This funding opportunity supports innovative research teams using non-human animal models to develop advanced methods for measuring and analyzing behavior in relation to environmental factors.

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological complications. Strategies to address viral latency include silencing of HIV transcription and reactivation and clearance. The goal of this initiative is to support research aimed at (1) identification of targets and pathways by which transcriptional activity of HIV can be suppressed in HIV reservoirs including the CNS in people with SUD, and (2) application of emerging small molecule drug discovery approaches to identify novel compounds that can be utilized as pharmacological probes and as drugs to suppress HIV transcription in people with HIV-SUD comorbidity.

This grant provides funding to national organizations focused on improving lupus awareness, diagnosis, treatment, and self-management among affected populations, particularly women aged 15 to 44.

This funding opportunity provides financial support to nonprofit organizations and educational institutions to implement and evaluate anti-stigma interventions that improve access to HIV care and prevention services across the U.S.

This funding opportunity supports small-scale research projects that analyze existing genomic data to advance understanding of dental, oral, and craniofacial health, particularly focusing on health disparities and biological pathways for intervention.

The "Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline" grant is a $20 million funding opportunity from the National Institutes of Health, aimed at supporting innovative clinical trials that develop and test pharmacological and non-pharmacological interventions for Alzheimer's disease and age-related cognitive decline over a five-year period.

This grant provides funding for researchers to develop a vaccine against Kaposi sarcoma herpesvirus (KSHV), aiming to prevent infection and treat related diseases in affected populations.

Program Summary • The Grantee shall deliver mental health services to individuals who are Deaf, Hard of Hearing or DeafBlind by utilizing a culturally affirmative approach. This approach will adhere to the Americans with Disabilities Act. The culturally affirmative approach shall serve these populations in an individualized manner and shall provide any level of outpatient mental health service delivered by staff who directly provide such in the individual's language and communication mode. Additionally, these staff will exhibit a distinct knowledge base, specialized clinical skills, and specialized cultural linguistic skills. The service delivery may also include staff who exhibit a knowledge base in serving these minority populations and utilize reasonable accommodations for the individual's language needs and communication modes. The Grantee's staff providing mental health services may include case managers, therapists, counselors, and/or psychiatrists. The Grantee shall communicate in an accessible manner, by utilizing Video Phones, TTYs, licensed sign language interpreters and/or other reasonable accommodations according to the individual's needs. Funding Priorities or Focus Areas • IDHS is working to counteract systemic racism and inequity, and to prioritize and maximize diversity throughout its service provision process. This work involves addressing existing institutionalized inequities, aiming to create transformation, and operationalizing equity and racial justice. It also focuses on the creation of a culture of inclusivity for all regardless of race, gender, religion, sexual orientation, or ability. Project Description • The Grantee must deliver mental health services to individuals who are Deaf, Hard of Hearing or DeafBlind by utilizing a culturally affirmative approach. This approach will adhere to the Americans with Disabilities Act. Each of these minority populations have unique cultural and linguistic needs, which are not exclusively homogeneous. Therefore, the culturally affirmative approach must serve these populations in an individualized manner. An individual who is Deaf, Hard of Hearing or DeafBlind, that is served by this grant funding, may reside or be originally from any county in Illinois. The cultural affirmative service delivery must provide any level of outpatient mental health service delivered by staff who directly provide such in the individual’s language and communication mode. Additionally, these staff will exhibit a distinct knowledge base, specialized clinical skills, and specialized cultural linguistic skills. The service delivery may also include staff who exhibit a knowledge base in serving these minority populations, and utilize reasonable accommodations for the individual’s language needs and communication modes. The Grantee’s staff providing mental health services may include, but are not limited to: case managers, therapists, counselors, and/or psychiatrists. The Grantee must communicate in an accessible manner, by utilizing Video Phones, TTYs, licensed sign language interpreters and/or other reasonable accommodations according to the individual’s needs. There are community networks across the state of Illinois that serve as a separate referral source for these populations. In these networks, information is communicated on how and where to access these services that are delivered in a cultural affirmative approach. The Grantee must serve as an embedded entity of these community networks as it relates to their cultural affirmative service delivery of mental health services. The Grantee’s staff will outreach, collaborate, and network across various service systems to effectively address these challenges. As part of this, the Grantee will assist individuals served in addressing the complex language, cultural, clinical, and administrative challenges when navigating the various service systems and their associated processes. Most often, these systems’ information is not readily accessible in the population’s native language and communication mode. Specifically, the Grantee’s staff will assist individuals in identifying and linking to other applicable providers, how to access their services, and/or apply for applicable benefits. Additionally, there is an absence of any evidence-based mental health treatment developed for or evaluated for use with these populations. The grantee must adapt evidence-based mental health treatment using an effective and culturally affirmative approach. This must include but is not limited to: consideration of the individual’s culture, community, beliefs, thinking and learning style, communication mode(s), and language needs. This funding is designated to support costs associated with cultural affirmative service delivery approach; the necessary outreach, networking, and collaboration necessary as an embedded entity providing for these populations; adaptation of evidence-based mental health treatment; and paying for licensed sign language interpreter services. The mental health services provided are billed to Healthcare and Family Services’ Illinois Medicaid as well as any of their associated Medicaid Managed Care Organizations (MCOs). Therefore, the Grantee must also have certification as (Comprehensive) Community Mental Health Center (CMHC), as defined in Part 132, Subparts B and C.

This funding opportunity supports community-led initiatives in Philadelphia that aim to reduce violence and enhance neighborhood safety, particularly for young Black and brown men, through various programs like job training, educational outreach, and trauma-informed care.

This funding opportunity provides financial support to higher education institutions and nonprofits to establish or renew research centers focused on advancing studies related to Alzheimer's disease and related dementias, promoting collaboration, innovation, and diversity in research efforts.

This grant provides $100,000 to public or nonprofit organizations in Arizona to create partnerships that connect community health workers with clinical settings to combat chronic diseases in underserved communities.

This funding opportunity provides financial support to researchers with active NIH grants to quickly adapt their projects to address urgent public health crises that have emerged unexpectedly.

This funding opportunity supports short-term research projects that explore the ethical challenges arising from advancements in neurotechnology and brain science, encouraging collaboration between ethicists and neuroscientists.

The "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes" grant aims to fund research projects that prepare for clinical trials in rare diseases by developing effective strategies for testing potential treatments or diagnostics, improving success rates with robust biomarkers and assessment measures, or by understanding the progression of a rare disease to design future clinical trials.

This funding opportunity provides financial support for research projects aimed at overcoming barriers to HIV prevention for marginalized individuals who use substances, focusing on improving access to and retention in PrEP care.

This funding opportunity supports U.S. research institutions in training and developing Ph.D. students from underrepresented groups in biomedical research to address national health-related challenges.

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multidisciplinary and multi-level research designed to develop and/or test interventions to optimize care of persons with Type 2 diabetes from populations with health/health care disparities concordant with evidence-based guidelines. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. Proposed projects would be expected to develop and/or test patient-centered strategies, which in addition to optimal glycemic control, would aim at completing other recommended guidelines (e.g., annual eye/foot and urine albumin exam, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin and influenza/pneumonia vaccines).